Cargando…
Case report: Optimized ruxolitinib-based therapy in an infant with familial hemophagocytic lymphohistiocytosis type 3
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare and fatal autosomal recessive immune disorder characterized by uncontrolled activation of T and NK cells, macrophages, and overproduction of inflammatory cytokines. Early hematopoietic cell transplantation (HCT) is required for long-term su...
Autores principales: | Niizato, Daiki, Isoda, Takeshi, Mitsuiki, Noriko, Kaneko, Shuya, Tomomasa, Dan, Kamiya, Takahiro, Takagi, Masatoshi, Imai, Kohsuke, Kajiwara, Michiko, Shimizu, Masaki, Morio, Tomohiro, Kanegane, Hirokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731208/ https://www.ncbi.nlm.nih.gov/pubmed/36505485 http://dx.doi.org/10.3389/fimmu.2022.977463 |
Ejemplares similares
-
Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
por: Tomomasa, Dan, et al.
Publicado: (2021) -
Case report: HLA-haploidentical hematopoietic cell transplant with posttransplant cyclophosphamide in a patient with leukocyte adhesion deficiency type I
por: Yamashita, Motoi, et al.
Publicado: (2022) -
Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission
por: Noguchi, Yusuke, et al.
Publicado: (2018) -
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis
por: Song, Yue, et al.
Publicado: (2023) -
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
por: Keenan, Camille, et al.
Publicado: (2021)